Diferencias en el manejo de la artritis reumatoide precoz y establecida
作者： Santos Castañeda , Federico Navarro , Cristina Fernández-Carballido , Carmelo Tornero , Elena Marced
DOI: 10.1016/J.REUMA.2010.08.001
关键词: Methotrexate 、 Chart review 、 Drug 、 Early ra 、 Rheumatoid arthritis 、 Clinical Practice 、 Medicine 、 Surgery 、 Internal medicine
摘要: Objective: To assess the differences in clinical and therapeutic management of early established rheumatoid arthritis (RA) practice. Methods: Retrospective multicentre study including 360 patients diagnosed with RA. During 12 months prior to study, onset, sociodemographic, data were collected by chart review. Results: A total 152 RA 208 studied. 97.5% had received disease-modifying anti-rheumatic drugs (DMARDs) 43.6% a TNFa blocker between diagnosis start study. Established used blockers more frequently than (60,1% vs 21,1%, p < 0,001). Methotrexate was most commonly drug (70.6%). treatment change seen 79% 60.6% those dose
reumatologiaclinica.org
unirioja.es
elsevier.com参考文章(28)
Alice Klinkhoff???, Biological agents for rheumatoid arthritis: targeting both physical function and structural damage. Drugs. ,vol. 64, pp. 1267- 1283 ,(2004) , 10.2165/00003495-200464120-00001
Loreto Carmona, Javier Ballina, Armando Laffon, Rafael Gabriel, Proyecto EPISER 2000: prevalencia de enfermedades reumáticas en la población española.Metodología, resultados del reclutamiento y características de la población Revista española de reumatología: Órgano Oficial de la Sociedad Española de Reumatología. ,vol. 28, pp. 18- 25 ,(2001)
van Riel Pl, van 't Hof M, van de Putte Lb, van der Heijde Dm, Development of a disease activity score based on judgment in clinical practice by rheumatologists The Journal of Rheumatology. ,vol. 20, pp. 579- 581 ,(1993)
Jerry M. Greene, Dorothy A. Johnson, Larry G. Anderson, Robert A. Yood, Robert W. Simms, Guidelines for the Management of Rheumatoid Arthritis ,(2002)
Sergio Schwartzman, Roy Fleischmann, G James Morgan, Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis? Arthritis Research & Therapy. ,vol. 6, pp. 1- 9 ,(2004) , 10.1186/AR1013
Sanders M, A review of controlled clinical trials examining the effects of antimalarial compounds and gold compounds on radiographic progression in rheumatoid arthritis. The Journal of Rheumatology. ,vol. 27, pp. 523- 529 ,(2000)
José Antonio Lozano, Artritis reumatoide (I). Etiopatogenia, sintomatología, diagnóstico y pronóstico Offarm. ,vol. 20, pp. 94- 101 ,(2001)
P. Lázaro, C. Hernández-García, GUIPCAR: una guía de práctica clínica para el manejo de la artritis reumatoide en España Revista española de reumatología: Órgano Oficial de la Sociedad Española de Reumatología. ,vol. 29, pp. 94- 98 ,(2002)
Cristina Lajas, Lydia Abasolo, Boutayeb Bellajdel, César Hernández-García, Loreto Carmona, Emilio Vargas, Pablo Lázaro, Juan A. Jover, Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study Arthritis Care and Research. ,vol. 49, pp. 64- 70 ,(2003) , 10.1002/ART.10905
A. M. van Gestel, M. L. L. Prevoo, M. A. van't Hof, M. H. van Rijswijk, L. B. A. van de Putte, P. L. C. M. van Riel, Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria Arthritis & Rheumatism. ,vol. 39, pp. 34- 40 ,(1996) , 10.1002/ART.1780390105